AOD-9604 is a growth-hormone-derived peptide investigated for metabolic effects. Published human safety summaries do not establish that it produces clinically useful fat loss or improves performance.
Key points
- Human exposure has been reported, but efficacy claims need their own controlled outcomes.
- A pooled safety analysis cannot establish long-term safety of unregulated products.
- Preclinical metabolic mechanisms should not be advertised as established human effects.
What the literature shows
Stier reported pooled tolerability data from human AOD-9604 studies. The paper addresses observed safety and tolerability, not proof of meaningful fat loss in healthy exercisers.
Moré discussed metabolism and safety in a separate publication. Neither analysis substitutes for a replicated, adequately powered human efficacy trial for a marketed performance claim.
What remains unknown
- Reproducible effects on weight, body composition or sport performance remain unclear.
- Safety under repeated unsupervised exposure and combined drug use is unestablished.
Safety and monitoring implications
- Do not interpret an absence of a signal in limited studies as assurance that retail preparations are safe.
- Check medical advice before acting on claims drawn from animal models or product marketing.
Cited literature
- 1.Stier H. (2013). Safety and tolerability of the hexadecapeptide AOD9604 in humans. Journal of Endocrinology and Metabolism. Find on PubMed
- 2.Moré A. (2014). Safety and metabolism of AOD9604, a novel nutraceutical ingredient for improved metabolic health. Journal of Endocrinology and Metabolism. Find on PubMed
Community reports
Anecdotal — not scientific evidence
Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.
Editorial evidence status
MixedNo independently verified community reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.
Buying AOD-9604 in Australia: what to check first
APEDRA does not sell AOD-9604 or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.
- Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
- Check independent review platforms, not only reviews hosted on the seller's own site.
- Read the shipping, returns and refund policies before ordering.
- Be wary of prices far below the market or exaggerated results claims.
Compare Australian vendors independently · how we assess suppliers
Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.
This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.